Blue Horseshoe Stocks: USRM, ICLD Follow-ups & More

U.S. Stem Cell, Inc. USRM
We’ve been tracking USRM very closely over the past few weeks, since initially mentioning it on the morning of February 27th and witnessing a huge subsequent increase( .014-.0545,+289%). We monitored the consolidation off of that high down to .0175, and once again signaled that it was time to give it our close attention last week on the 15th.

The rebound that has since occurred has been very nice, with USRM surging back to .053 yesterday, a jump of 203% over its .0175 swing low. So that’s twice now, in the span of less than a month that we’ve seen a 200% move out of this play. We’re obviously going to continue following it, with the type of price action and volatility we’ve seen so far, USRM is currently a swing-trader’s paradise.

InterCloud Systems, Inc. ICLD

We also had a ringer with ICLD earlier this month, when we signaled it on the 2nd before the stock took off from a low of .0157 to a high .0985, a 527% rip. After watching it consolidate off of those highs for a few days, re brought it back to readers’ attention in yesterday’s premarket report, and our attempted timing of the reversal couldn’t have worked any better.

From an early low of .0302, the stock steadily made its way up to a high .0439 shortly after 1PM, for an intraday spike of 45% and held more than half of its daily gains into the close, so this one will also remain on our watchlist in coming sessions.

Northern Dynasty Minerals, Ltd. NAK

We tagged NAK last Thursday after watching the stock search out a bottom for quite awhile. The stock did bounce, and has thus far posted a 31% increase, reaching 1.58 yesterday and closing just a tick below at 1.57, as you can see on the included snapshot.

Also on the chart, we can see that the RSI is on the verge of cracking the 50-line, and the MACD has just crossed in a bullish manner. Conditions seem to be ripe for the possibility of a continued rebound, so we’ll pay close attention to NAK in sessions to come.

Extended Watchlist:

Comments are closed.